Fiomi Diagnostics AB, founded in November 2010, is a wholy owned subsidiary of Trinity Biotech plc. The team, headed by Ove Öhman (CEO), draws on the experience of senior management and key personnel from Åmic AB. 

The team is developing game-changing products for near patient testing that offer central lab performance in a reliable, easy to use and affordable format.

We are currently seeking healthy individuals to participate in a clinical study to determine normal reference values for our Troponin I test for use as an aid in the diagnosis of Myocardial Infarction.

Obs. normalvärdesstudien genomförs i  FoodFiles lokaler,  Dag Hammarskölds väg 36B, Husaren, Uppsala Science Park.